Literature DB >> 30176341

Promotion of differentiation in developing mouse cerebellar granule cells by a cell adhesion molecule BT-IgSF.

Kasumi Higashine1, Kei Hashimoto2, Emi Tsujimoto3, Yuko Oishi1, Yokichi Hayashi4, Yasunori Miyamoto5.   

Abstract

Brain- and testis-specific immunoglobulin superfamily (BT-IgSF) (also known as IgSF11), one of the immunoglobulin superfamily proteins, is a cell adhesion molecule, expressed in the developing cerebellum. We hypothesized that BT-IgSF might have some function in the development of cerebellum, although the physiological roles of BT-IgSF in the cerebellum remain unclear. To investigate the role of BT-IgSF in the development of mouse cerebellum, we first determined the presence of BT-IgSF in the newborn mouse cerebellum; its expression level was found to be much higher than that in the adults. BT-IgSF was abundantly expressed in the molecular layer, where cerebellar granule cell precursors (CGCPs) are in the differentiation stage during migration. We subsequently analyzed the effects of BT-IgSF-knockdown and -overexpression on the proliferation and differentiation of primary cultured CGCPs. BT-IgSF suppressed the proliferation of CGCPs, and promoted their differentiation into cerebellar granule cells. Taken together, our results suggested that BT-IgSF is one of the important cell adhesion molecules that regulate the developmentof mouse cerebellum.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BT-IgSF; Cerebellar granule cell; Differentiation; Immunoglobulin superfamily

Mesh:

Substances:

Year:  2018        PMID: 30176341     DOI: 10.1016/j.neulet.2018.08.049

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95.

Authors:  Hyunsoo Kim; Noriko Takegahara; Matthew C Walsh; Sarah A Middleton; Jiyeon Yu; Jumpei Shirakawa; Jun Ueda; Yoshitaka Fujihara; Masahito Ikawa; Masaru Ishii; Junhyong Kim; Yongwon Choi
Journal:  Bone Res       Date:  2020-02-10       Impact factor: 13.567

Review 2.  IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy.

Authors:  Xi-Yang Tang; Yan-Lu Xiong; Xian-Gui Shi; Ya-Bo Zhao; An-Ping Shi; Kai-Fu Zheng; Yu-Jian Liu; Tao Jiang; Nan Ma; Jin-Bo Zhao
Journal:  Biomark Res       Date:  2022-07-13

3.  Structural Basis of VSIG3: The Ligand for VISTA.

Authors:  Xiaoxue Xie; Caiping Chen; Wenting Chen; Jingwei Jiang; Lanlan Wang; Tingting Li; Hongbin Sun; Jun Liu
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

4.  IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95.

Authors:  Hyunsoo Kim; Noriko Takegahara; Matthew C Walsh; Sarah A Middleton; Jiyeon Yu; Jumpei Shirakawa; Jun Ueda; Yoshitaka Fujihara; Masahito Ikawa; Masaru Ishii; Junhyong Kim; Yongwon Choi
Journal:  Bone Res       Date:  2020-02-10       Impact factor: 13.567

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.